Learn more about our free light chain testing solution.
Improve patient management and outcomes with FLC testing
N Latex FLC kappa and lambda assays are highly sensitive reagents for reliable management of patients with monoclonal gammopathies.
When tested in serum, plasma and urine,1 FLC measurements are used as an aid in the diagnosis and monitoring of multiple myeloma and various other diseases with FLC involvement. In CSF, FLC kappa can aid in the diagnosis of multiple sclerosis.1
Nephelometry-based detection method that complies with IMWG guidelines for free light chain testing.
High specificity based on monoclonal antibodies for sound diagnoses.
Confident monitoring through excellent lot-to-lot consistency.
Smooth transition due to clinical concordance with other methods.
Pre-reaction protocols that ensure antigen-excess security for reliable results and less retesting.
Reduced waste, time, and cost through flexible packaging and lot-independent controls and calibrators.
Automatic dilutions that help reduce hands-on time and improve workflow.
After evaluating the performance and workflow benefits, the hospital made the switch to the Siemens Healthineers solution.
ESMO and IMWG guidelines recommend nephelometry with any free light chain testing method.
See even more reasons to chose our solution.
Review recent research and learn about the value of the Reiber diagram in interpretation of FLC test results for simplified MS diagnosis.
Add confidence to screening and monitoring of monoclonal gammopathies with N Latex FLC kappa and N Latex FLC lambda assays on the Atellica® NEPH 630 System,1 BN™ II System, BN ProSpec® System, and Atellica® CH 930 Analyzer.